Organization Profile

You just read:

Investigational Drug AZD9291 Shows Clinical Responses in Patients With Advanced NSCLC Who Have Previously Failed on Established EGFR TKIs

News provided by

AstraZeneca

May 31, 2014, 09:40 ET